MSN Laboratories Private Limited — Cabazitaxel Exporter Profile
Indian Pharmaceutical Exporter · #2 for Cabazitaxel · $1.6M export value · DGFT Verified
MSN Laboratories Private Limited is the #2 Indian exporter of Cabazitaxel with $1.6M in export value and 37 verified shipments. MSN Laboratories Private Limited holds a 17.0% market share in Cabazitaxel exports across 8 countries. The company exports 32 pharmaceutical products worth $252.1M across 15 therapeutic categories.
MSN Laboratories Private Limited — Cabazitaxel Export Profile: Buyers & Destinations
Where Does MSN Laboratories Private Limited Export Cabazitaxel?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MALTA | $513.3K | 18 | 47.6% |
| SOUTH AFRICA | $215.6K | 5 | 20.0% |
| CHILE | $150.0K | 3 | 13.9% |
| UNITED KINGDOM | $100.0K | 2 | 9.3% |
| PERU | $58.8K | 2 | 5.5% |
| KENYA | $27.7K | 5 | 2.6% |
| AUSTRALIA | $12.8K | 1 | 1.2% |
| POLAND | $85 | 1 | 0.0% |
MSN Laboratories Private Limited exports Cabazitaxel to 8 countries. The largest destination is MALTA accounting for 47.6% of MSN Laboratories Private Limited's Cabazitaxel shipments, followed by SOUTH AFRICA (20.0%) and CHILE (13.9%). These destinations reflect MSN Laboratories Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Cabazitaxel from MSN Laboratories Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MSN LABS CHILE SPA | CHILE | $150.0K | 3 |
| TO THE ORDER OF | MALTA | $120.4K | 4 |
| PHARMADOX HEALTHCARE LTD., | MALTA | $116.6K | 3 |
| PHARMADOX HEALTHCARE LTD | MALTA | $112.6K | 5 |
| TILLOMED LABORATORIES LTD | UNITED KINGDOM | $100.0K | 2 |
| ADCOCK INGRAM CRITICAL CARE PTY LIMITED | SOUTH AFRICA | $87.8K | 2 |
| PHARMADOX HEALTHCARE LIMITED | MALTA | $86.5K | 4 |
| ADCOCK INGRAM CRITICAL CARE PTY LTD | SOUTH AFRICA | $81.3K | 2 |
| TILLOMED MALTA LIMITED | MALTA | $77.2K | 2 |
| MSN LABS PERU SAC CAL AMADOR | PERU | $58.8K | 2 |
MSN Laboratories Private Limited supplies Cabazitaxel to 15 buyers globally. The largest buyer is MSN LABS CHILE SPA (CHILE), followed by TO THE ORDER OF (MALTA) and PHARMADOX HEALTHCARE LTD., (MALTA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Cabazitaxel Export Value and How Much Does MSN Laboratories Private Limited Contribute?
India exported $5.8M worth of Cabazitaxel through 307 shipments from 59 suppliers to 49 countries, serving 107 buyers globally. MSN Laboratories Private Limited contributes $1.6M to this total, accounting for 17.0% of India's Cabazitaxel exports. MSN Laboratories Private Limited ships Cabazitaxel to 8 countries through 15 buyers.
What Is the Average Shipment Value for MSN Laboratories Private Limited's Cabazitaxel Exports?
MSN Laboratories Private Limited's average Cabazitaxel shipment value is $42.4K per consignment, based on 37 shipments totaling $1.6M. The largest destination is MALTA (47.6% of MSN Laboratories Private Limited's Cabazitaxel exports).
How Does MSN Laboratories Private Limited Compare to Other Indian Cabazitaxel Exporters?
MSN Laboratories Private Limited ranks #2 among 59 Indian Cabazitaxel exporters with a 17.0% market share. The top 3 exporters are INTAS PHARMACEUTICALS LIMITED ($3.5M), MSN LABORATORIES PRIVATE LIMITED ($1.6M), DR REDDY S LABORATORIES LIMITED ($150.0K). MSN Laboratories Private Limited processed 37 shipments to 8 destination countries.
What Cabazitaxel Formulations Does MSN Laboratories Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CABAZITAXEL ADCO CABAZITAXEL INJECTION 60MG/1.5ML)- SOUTH AFRICA- ADNOS | $87.8K | 2 |
| XATIZA 60-(CABAZITAXEL INJ 1X1'S) -MSN PE | $58.8K | 2 |
| MSN PHARMA CABAZITAXEL 40MG ML X1 ALVOGEN ZENTIVA RO BG FOC CABAZITAXEL 40MG MLX1 ALVOGEN ZENTIVA RO BG QYT 318 NOS | $50.0K | 1 |
| MSN PHARMA CABAZITAXEL 40MG ML VIAL 60MG 1 5ML CZ SK 1 S | $50.0K | 1 |
| MSN PHARMA CABAZITAXEL 40MG/ML X1 ALVOGEN-ZENTIVA PL/IS ALONG WITH FOC QTY: 258NOS | $50.0K | 1 |
| XATIZA 60 CABAZITAXEL INJ 60 MG/VIAL-CL | $50.0K | 1 |
| CABAZITAXEL 60MG FOR SOL x 1 UK (750 X 1's PACK = 750 NOs ) | $50.0K | 1 |
| XATIZA 60(CABAZITAXEL INJ 60MG/VIAL)-CLNOS | $50.0K | 1 |
| CABAZITAXEL ADCO CABAZITAXEL INJECTION 60MG/1.5ML)- SOUTH AFRICA- AD - BATCH NO CSE02013D | $50.0K | 1 |
| CABAZITAXEL 40MG/ML X1 ALVOGEN-ZENTIVA | $50.0K | 1 |
MSN Laboratories Private Limited exports 32 distinct Cabazitaxel formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CABAZITAXEL ADCO CABAZITAXEL INJECTION 60MG/1.5ML)- SOUTH AF with 2 shipments worth $87.8K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Cabazitaxel to Key Markets
What MSN Laboratories Private Limited must comply with to export Cabazitaxel to its top destination countries
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does MSN Laboratories Private Limited Compare to Nearest Cabazitaxel Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LIMITED | $3.5M | 108 | 9 | $32.8K |
| 2 | MSN LABORATORIES PRIVATE LIMITED ★ | $1.6M | 37 | 8 | $42.4K |
| 3 | DR REDDY S LABORATORIES LIMITED | $150.0K | 3 | 3 | $50.0K |
| 4 | DR REDDYS LABORATORIES LIMITED | $150.0K | 3 | 3 | $50.0K |
MSN Laboratories Private Limited ranks #2 among 59 Indian Cabazitaxel exporters. Average shipment value of $42.4K compared to the market average of $98.5K. The closest competitors by value are INTAS PHARMACEUTICALS LIMITED and DR REDDY S LABORATORIES LIMITED.
Which Indian Ports Ship Cabazitaxel Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 48 | 15.6% |
| SAHAR AIR CARGO ACC (INBOM4) | 45 | 14.7% |
| AHEMDABAD AIR | 37 | 12.1% |
| AHEMDABAD AIR ACC (INAMD4) | 32 | 10.4% |
| HYDERABAD AIR | 25 | 8.1% |
| MUNDRA SEA (INMUN1) | 19 | 6.2% |
| Hyderabad Air | 12 | 3.9% |
| DELHI AIR CARGO ACC (INDEL4) | 9 | 2.9% |
What Other Advanced Oncology Products Does MSN Laboratories Private Limited Export?
MSN Laboratories Private Limited also exports these advanced oncology products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Cabazitaxel Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like MSN Laboratories. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major shipping lines to alter routes. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, impacting the timely delivery of pharmaceutical products. (livemint.com)
Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the imposition of tariffs on Indian pharmaceutical products poses a risk to export volumes, as higher tariffs can lead to increased costs and reduced competitiveness in the US market. (orfonline.org)
In the European Union, compliance with the Falsified Medicines Directive (FMD) requires stringent serialization and traceability measures. For companies like MSN Laboratories, adhering to these regulations is crucial to maintain market access and ensure the integrity of their supply chain.
MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practice (EU GMP) guidelines set rigorous quality benchmarks. Any lapses can lead to import bans, product recalls, and reputational damage.
MSN Laboratories' recent legal challenges, such as the patent litigation with Exelixis, Inc., highlight the importance of robust regulatory and intellectual property strategies. Ensuring compliance with evolving quality requirements and proactively addressing regulatory challenges are essential for sustaining export growth and market credibility.
About MSN Laboratories Private Limited
MSN Laboratories Private Limited exports 32 products worth $252.1M. Beyond Cabazitaxel, top products include Atorvastatin, Rosuvastatin, Ras, Oseltamivir, Calcium. View the complete MSN Laboratories Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cabazitaxel — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cabazitaxel shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: MSN Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 37 individual customs records matching MSN Laboratories Private Limited exporting Cabazitaxel, covering 32 formulations to 8 countries via 15 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 49+ countries, 107+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cabazitaxel Export Data from MSN Laboratories Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for MSN Laboratories Private Limited's Cabazitaxel exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MSN Laboratories Private Limited
Full Company Profile →
32 products · $252.1M total trade · 15 categories
Cabazitaxel Stats
Company Overview
Top Products by MSN Laboratories Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for MSN Laboratories Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cabazitaxel. For current shipment-level data, contact TransData Nexus.